DKK 2016 | Precision medicine for lymphoma: Defining the individual patient
Lorenz Trümper
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Lorenz Trümper, MD, from University Hospital of Göttingen, Göttingen, Germany, reviews the development of more tailored approaches for the treatment of lymphoma that have improved outcomes in patients.
Related videos

Venetoclax monotherapy for relapsed/refractory Waldenström’s macroglobulinemia
Jorge Castillo

Waldenström's PFS unaffected by ibrutinib dose reduction, for now
Jorge Castillo

Anti-CD19 CAR T-cell therapy in combination with ibrutinib for CLL/SLL
Saar Gill

Waldenström’s macroglobulinemia: a link between institution visited and survival
Stephen Ansell

An exciting time for CAR T-cell therapy: promising results for B-ALL, nHL and CLL
Stanley Riddell
More from Lorenz Trümper